• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与费用相关的不依从行为与糖尿病结局的关系。

The Association Between Cost-Related Non-Adherence Behaviors and Diabetes Outcomes.

机构信息

From the College of Pharmacy, University of Michigan (YC,WN); Department of Biostatistics, University of Michigan School of Public Health (GZ, XS); Department of Health Behavior and Health Education, University of Michigan School of Public Health (MP).

出版信息

J Am Board Fam Med. 2023 Feb 8;36(1):15-24. doi: 10.3122/jabfm.2022.220272R2.

DOI:10.3122/jabfm.2022.220272R2
PMID:36759134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10626976/
Abstract

BACKGROUND

We examined the impact of various comorbid conditions on diabetes and condition-specific cost-related nonadherence (CRN), and HbA1c in adults with diabetes.

METHODS

This was a cross-sectional analysis of participants with diabetes and poor glycemic control in an ongoing trial (n = 600). We computed prevalence of condition-specific CRN, prevalence of specific types of diabetes-related CRN by comorbid condition, prevalence of specific types of condition-specific CRN within each comorbidity, and the association between condition-specific and diabetes-related CRN and HbA1c for each comorbid condition.

RESULTS

Fifty-eight percent (n = 350) of participants reported diabetes-related CRN. Diabetes-related CRN rates were highest in those with liver problems (63%), anemia (61%), respiratory diseases (60%), and hyperlipidemia (60%). Condition-specific CRN rates were high in those with respiratory diseases (44%), back pain (41%), and depression (40%). Participants with cancer and kidney diseases reported the lowest rates of diabetes-related and condition-specific CRN. Delaying getting diabetes prescriptions filled was the most commonly reported form of diabetes-related CRN across all comorbid conditions and was the highest in those with liver problems (47%), anemia (46%), and respiratory diseases (45%). In adjusted models, those with back pain (beta-coefficient, 0.45; 95%CI 0.02-0.88; ) and hyperlipidemia (beta-coefficient, 0.50; 95%CI 0.11-0.88; ) who reported both diabetes-related and condition-specific CRN had higher HbA1c.

CONCLUSIONS

CRN in patients with diabetes is higher than in other comorbid conditions and is associated with poor diabetes control. These findings may be driven by higher out-of-pocket costs for medications to manage diabetes, lack of symptoms associated with poor diabetes control, or other factors, with implications for both clinicians and health insurance programs.

摘要

背景

我们研究了各种合并症对糖尿病患者的影响,以及与特定疾病相关的费用相关不依从(CRN)和糖化血红蛋白(HbA1c)。

方法

这是一项横断面分析,纳入了正在进行的试验中血糖控制不佳的糖尿病患者(n=600)。我们计算了特定类型的糖尿病相关 CRN 的患病率、每种合并症中特定类型的糖尿病相关 CRN 的患病率、每种合并症中特定类型的与疾病相关的 CRN 的患病率,以及每种合并症中与疾病相关的和糖尿病相关的 CRN 与 HbA1c 之间的关联。

结果

58%(n=350)的参与者报告了糖尿病相关的 CRN。有肝脏问题(63%)、贫血(61%)、呼吸系统疾病(60%)和血脂异常(60%)的患者中,糖尿病相关 CRN 的发生率最高。有呼吸系统疾病(44%)、背痛(41%)和抑郁(40%)的患者中,与疾病相关的 CRN 发生率较高。有癌症和肾脏疾病的患者报告了最低的糖尿病相关和与疾病相关的 CRN 发生率。延迟开糖尿病处方是所有合并症中最常见的糖尿病相关 CRN 形式,在有肝脏问题(47%)、贫血(46%)和呼吸系统疾病(45%)的患者中最高。在调整模型中,报告同时存在糖尿病相关和与疾病相关的 CRN 的背痛(β系数,0.45;95%CI 0.02-0.88;)和血脂异常(β系数,0.50;95%CI 0.11-0.88;)患者的 HbA1c 更高。

结论

糖尿病患者的 CRN 高于其他合并症,且与糖尿病控制不良有关。这些发现可能是由于管理糖尿病的药物自付费用较高、与糖尿病控制不良相关的症状缺乏,或其他因素导致的,这对临床医生和健康保险计划都有影响。

相似文献

1
The Association Between Cost-Related Non-Adherence Behaviors and Diabetes Outcomes.与费用相关的不依从行为与糖尿病结局的关系。
J Am Board Fam Med. 2023 Feb 8;36(1):15-24. doi: 10.3122/jabfm.2022.220272R2.
2
Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013-2018.美国成年人糖尿病患者的与费用相关的药物不依从性:2013-2018 年全国健康访谈调查。
Diabetes Care. 2022 Mar 1;45(3):594-603. doi: 10.2337/dc21-1757.
3
Cost-related medication nonadherence among over-indebted individuals enrolled in statutory health insurance in Germany: a cross-sectional population study.德国法定健康保险中负债人群的与费用相关的药物不依从性:一项横断面人群研究。
BMC Health Serv Res. 2019 Nov 26;19(1):887. doi: 10.1186/s12913-019-4710-0.
4
Social Determinants of Health, Cost-related Nonadherence, and Cost-reducing Behaviors Among Adults With Diabetes: Findings From the National Health Interview Survey.糖尿病成年人的健康社会决定因素、与费用相关的不依从性及降低费用行为:来自国家健康访谈调查的结果
Med Care. 2016 Aug;54(8):796-803. doi: 10.1097/MLR.0000000000000565.
5
Effect of Financial Stress and Positive Financial Behaviors on Cost-Related Nonadherence to Health Regimens Among Adults in a Community-Based Setting.在社区环境中,经济压力和积极财务行为对成年人与费用相关的健康方案治疗依从性的影响。
Prev Chronic Dis. 2016 Apr 7;13:E46. doi: 10.5888/pcd13.160005.
6
Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension.报告显示,在患有冠心病、糖尿病和/或高血压的老年患者中,药物不依从的发生率及其相关因素。
Res Social Adm Pharm. 2013 Nov-Dec;9(6):817-27. doi: 10.1016/j.sapharm.2012.12.002. Epub 2013 Jan 4.
7
Cost-related medication non-adherence among U.S. adults with diabetes.美国糖尿病患者的药物费用相关不依从性。
Diabetes Res Clin Pract. 2018 Sep;143:24-33. doi: 10.1016/j.diabres.2018.06.016. Epub 2018 Jun 23.
8
Association Between High Deductible Health Plans and Cost-Related Non-adherence to Medications Among Americans with Diabetes: an Observational Study.高免赔额健康计划与美国糖尿病患者药物费用相关不依从的相关性:一项观察性研究。
J Gen Intern Med. 2022 Jun;37(8):1910-1916. doi: 10.1007/s11606-021-06937-9. Epub 2021 Jul 29.
9
Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.美国的癌症病史、健康保险覆盖情况以及与费用相关的药物不依从和药物费用应对策略。
Value Health. 2019 Jul;22(7):762-767. doi: 10.1016/j.jval.2019.01.015. Epub 2019 May 16.
10
Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases.美国慢性肝病患者药物费用相关不依从性。
Mayo Clin Proc. 2021 Oct;96(10):2639-2650. doi: 10.1016/j.mayocp.2021.02.026. Epub 2021 Jun 11.

引用本文的文献

1
Financial Toxicity in Diabetes: The State of What We Know.糖尿病中的经济毒性:我们所知的现状。
Curr Diab Rep. 2025 May 13;25(1):32. doi: 10.1007/s11892-025-01588-0.
2
The impact of prescription drug insurance on cost related non-adherence to medications in Canada: A Heckman sample selection approach.加拿大处方药保险对与费用相关的药物不依从性的影响:Heckman 样本选择方法。
PLoS One. 2023 Aug 9;18(8):e0289776. doi: 10.1371/journal.pone.0289776. eCollection 2023.
3
More than skin deep: cyclic peptides as wound healing and cytoprotective compounds.

本文引用的文献

1
Association Between High Deductible Health Plans and Cost-Related Non-adherence to Medications Among Americans with Diabetes: an Observational Study.高免赔额健康计划与美国糖尿病患者药物费用相关不依从的相关性:一项观察性研究。
J Gen Intern Med. 2022 Jun;37(8):1910-1916. doi: 10.1007/s11606-021-06937-9. Epub 2021 Jul 29.
2
Correlates of financial toxicity in adult cancer patients and their informal caregivers.成年癌症患者及其非专业照护者的财务毒性相关因素。
Support Care Cancer. 2022 Jan;30(1):217-225. doi: 10.1007/s00520-021-06424-1. Epub 2021 Jul 13.
3
Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems.
不止于皮肤表面:环肽作为伤口愈合和细胞保护化合物
Front Cell Dev Biol. 2023 Jun 1;11:1195600. doi: 10.3389/fcell.2023.1195600. eCollection 2023.
癌症治疗的财务毒性:三个不同医疗体系下的财务负担分析。
JCO Oncol Pract. 2021 Oct;17(10):e1450-e1459. doi: 10.1200/OP.20.00890. Epub 2021 Apr 7.
4
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84. doi: 10.2337/dc21-S006.
5
Assessment of Financial Toxicity Among Older Adults With Advanced Cancer.评估晚期癌症老年患者的财务毒性。
JAMA Netw Open. 2020 Dec 1;3(12):e2025810. doi: 10.1001/jamanetworkopen.2020.25810.
6
Cost-Related Medication Non-adherence, Cost Coping Behaviors, and Cost Conversations Among Individuals with and Without Diabetes.糖尿病患者与非糖尿病患者中与费用相关的药物治疗不依从、费用应对行为及费用沟通情况
J Gen Intern Med. 2021 Sep;36(9):2867-2869. doi: 10.1007/s11606-020-06176-4. Epub 2020 Sep 1.
7
Study protocol: CareAvenue program to improve unmet social risk factors and diabetes outcomes- A randomized controlled trial.研究方案:改善未满足的社会风险因素和糖尿病结局的 CareAvenue 计划-一项随机对照试验。
Contemp Clin Trials. 2020 Feb;89:105933. doi: 10.1016/j.cct.2020.105933. Epub 2020 Jan 7.
8
Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.评估与老年美国医疗保险受益人药物费用相关不依从相关因素的重要性。
Drugs Aging. 2019 Dec;36(12):1111-1121. doi: 10.1007/s40266-019-00715-3.
9
Analysis of State Insurance Coverage for Nonpharmacologic Treatment of Low Back Pain as Recommended by the American College of Physicians Guidelines.美国医师协会指南推荐的非药物治疗腰痛的国家保险覆盖情况分析。
Glob Adv Health Med. 2019 Jul 29;8:2164956119855629. doi: 10.1177/2164956119855629. eCollection 2019.
10
Insurer Coverage of Nonpharmacological Treatments for Low Back Pain-Time for a Change.保险公司对腰痛非药物治疗的承保范围——是时候做出改变了。
JAMA Netw Open. 2018 Oct 5;1(6):e183037. doi: 10.1001/jamanetworkopen.2018.3037.